Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.13 USD | +17.39% | +8.23% | +107.69% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 998.9 | 1,857 | 145.8 | 361.6 | - | - |
Enterprise Value (EV) 1 | 998.9 | 1,539 | -155 | 137.3 | -34.04 | 233.8 |
P/E ratio | -2.99 x | -15.8 x | -0.75 x | -2.11 x | -1.96 x | -3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | 5.42 x |
EV / Revenue | - | - | - | - | - | 3.51 x |
EV / EBITDA | - | -13.6 x | 0.75 x | -0.84 x | 0.22 x | -1.25 x |
EV / FCF | -25.7 x | -15.5 x | 0.93 x | -1.11 x | 0.2 x | -1.17 x |
FCF Yield | -3.9% | -6.43% | 108% | -90.3% | 491% | -85.3% |
Price to Book | - | 5.28 x | 0.59 x | 1 x | 0.76 x | - |
Nbr of stocks (in thousands) | 50,297 | 56,637 | 59,027 | 70,494 | - | - |
Reference price 2 | 19.86 | 32.79 | 2.470 | 5.130 | 5.130 | 5.130 |
Announcement Date | 3/23/22 | 3/23/23 | 2/27/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 66.7 |
EBITDA 1 | - | - | -113 | -207.8 | -162.5 | -157.3 | -187.2 |
EBIT 1 | - | -67.15 | -113.1 | -208 | -164.5 | -179.7 | -160.1 |
Operating Margin | - | - | - | - | - | - | -240.05% |
Earnings before Tax (EBT) 1 | - | -83.75 | -108.4 | -193 | -161.9 | -193.3 | -154.3 |
Net income 1 | -28.17 | -85.3 | -108.4 | -193 | -159.5 | -182.9 | -150.4 |
Net margin | - | - | - | - | - | - | -225.5% |
EPS 2 | -14.16 | -6.650 | -2.070 | -3.300 | -2.428 | -2.621 | -1.710 |
Free Cash Flow 1 | - | -38.91 | -99.05 | -167 | -124 | -167 | -199.5 |
FCF margin | - | - | - | - | - | - | -299.11% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 8/20/21 | 3/23/22 | 3/23/23 | 2/27/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | -22.73 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -17.83 | -22.75 | -20.4 | -31.42 | -38.57 | -42.55 | -57.14 | -57.95 | -50.35 | -41.77 | -40.66 | -41.01 | -43.05 | -41.28 | -41.83 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -17.77 | -22.73 | -20.02 | -30.46 | -35.21 | -38.93 | -53.25 | -54.03 | -46.75 | -38.57 | -39.45 | -40.14 | -43.62 | -48.2 | -48.78 |
Net income 1 | -17.77 | -22.73 | -20.02 | -30.46 | -35.21 | -38.93 | -53.25 | -54.03 | -46.75 | -38.57 | -39.24 | -39.48 | -42.18 | -39.6 | -40.14 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.4300 | -0.4500 | -0.3900 | -0.5900 | -0.6200 | -0.6800 | -0.9100 | -0.9200 | -0.7900 | -0.6200 | -0.5900 | -0.5800 | -0.6057 | -0.5800 | -0.5750 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/23/22 | 5/12/22 | 8/15/22 | 11/3/22 | 3/23/23 | 5/11/23 | 8/10/23 | 11/9/23 | 2/27/24 | 5/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 318 | 301 | 224 | 396 | 128 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -38.9 | -99 | -167 | -124 | -167 | -200 |
ROE (net income / shareholders' equity) | - | - | -34.3% | -64.6% | -53.3% | -33.5% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 6.210 | 4.170 | 5.130 | 6.760 | - |
Cash Flow per Share | - | - | -1.880 | - | - | - | - |
Capex 1 | - | 0.26 | 0.28 | 0.51 | 0.5 | 1.83 | 3 |
Capex / Sales | - | - | - | - | - | - | 4.5% |
Announcement Date | 8/20/21 | 3/23/22 | 3/23/23 | 2/27/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.69% | 362M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-0.96% | 21.83B | |
-11.16% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- VTYX Stock
- Financials Ventyx Biosciences, Inc.